SOLD: German importer/exporter, GDP & narcotics licences, exclusive hospital contract
Cannabis wholesaler and distributor in Germany holding GDP & narcotics licences and an exclusive supply contract is poised for rapid growth through addition of new brands/products
Listing ID:
15948229480
Licence(s) Held:
GDP, controlled drug licence, 52a Wholesaler license, AMradV, Para. 3, Dronabinol, and manufacturing license
Listing Details:
German licenced wholesaler importing medicinal cannabis for sale to other distibutors and pharmacies in Germany, offering a gateway to the rest of the EU
Holds unique, exclusive contract for the sale of medical cannabis products into hospital pharmacies
Existing supply agreements are in place including production partners that meet the highest pharmaceutical quality standards according to GMP guidelines
Staff are open to staying on for future operations
Great opportunity to tap in to the German medical cannabis market – over 19,000 German pharmacies to tap in to for direct wholesale distribution
Business encompasses a turnkey operation, break-even financials, low operating costs, leased licensed premises and considerable IP/market knowledge,
Seeking outright divestiture of the licences, IP, leased office and going concern business for the bargain price of 475,000 Euros.
OUR NEWEST CANNABIS BUSINESS LISTINGS
Explore the newest cannabis business opportunities hitting the market. If you're looking to invest, acquire, or expand your enterprise, these listings are the ideal starting point to grow your footprint in the cannabis industry.
28790904174
Licensed 8,500 ft² Cannabis Cultivation & Nursery Facility on 23 Acres Near Montreal, QC for $1.7M OBO
Opportunity to acquire a fully built-out, cannabis cultivation buildings located 30 minutes east of Montreal, featuring two purpose-built cultivation and nursery buildings on 23 acres for 1.7M o.b.o
44498920359
Early-Stage UK Medical Cannabis Platform – Licensed Market Entry Opportunity
Unique opportunity to invest in a pre-operational UK medical cannabis platform being established through a structured regulatory and licensing pathway, led by an experienced sector operator and set to operate all steps from import to patient.
54492796721
Profitable German direct-to-patient medical cannabis platform for €1.95M OBO — €3M+ revenue, 25% profit contribution, fully operational asset package
Unique opportunity to acquire a fully operational, profitable e-health platform serving medical cannabis patients across Germany through an integrated online consultation, prescription, and pharmacy fulfilment model.